| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/06/2008 | CN101235387A Adenoids viral vectors for constructing endogenesis promoter to regulate and control exogenous gene |
| 08/06/2008 | CN101235364A Newcastle disease virus D90 strain and application thereof |
| 08/06/2008 | CN101235102A Method for preparing folic acid coupling hydroxypropyl chitosan nano particles |
| 08/06/2008 | CN101235088A Preparation of anti-human seminoprotein specificity single chain antibody and application method thereof |
| 08/06/2008 | CN101235079A Short peptide for inhibiting growing of liver cancer cell and application thereof |
| 08/06/2008 | CN101235072A Oleanolic acid triterpene with A ring and C ring both containing multiple oxygen-containing substituents and use thereof |
| 08/06/2008 | CN101235071A Diene oleanolic acid pentacyclic triterpenes derivatives and use thereof |
| 08/06/2008 | CN101235070A Oleanane triterpene with A ring containing double bond and C ring containing conjugated ketenes, and use thereof |
| 08/06/2008 | CN101235069A Oleanane derivative with carbonyl and oxygen substituent at C ring and use thereof |
| 08/06/2008 | CN101235066A Novel toosendan fruit peel extract |
| 08/06/2008 | CN101235060A Isograndidentatin, preparation method thereof and application of the same in preparing antineoplastic medicament |
| 08/06/2008 | CN101235059A Phenylpropanoids derivatives, preparation method thereof and medical composition using the same as active component |
| 08/06/2008 | CN101235046A Novel vinblastine derivative, preparation method and use thereof, and medical composition containing the derivative |
| 08/06/2008 | CN101235004A Omega-amidosulphonic acid substituted hypocrellin derivatives, preparation method and application thereof |
| 08/06/2008 | CN101235003A 3,4,5,4'-tetramethoxy-alpha, beta-diphenylethane-3'-O-sulfuric ester sodium salt and application thereof |
| 08/06/2008 | CN101234951A Biphenyls compound and its preparation method and application |
| 08/06/2008 | CN101234788A Method for synthesizing antineoplastic medicine cisplatin |
| 08/06/2008 | CN101234205A High molecule adriamycin bonding medicine nano capsule with targeting function and preparation thereof |
| 08/06/2008 | CN101234204A High molecule bonding adriamycin medicine, nano capsule and preparation thereof |
| 08/06/2008 | CN101234203A Novel medical photosensitive agent for anti-tumor treatment and preparation thereof |
| 08/06/2008 | CN101234191A Use of human recombination hepatic stimulator substance for reinforcing anti-apoptosis of liver cancer cell and application thereof |
| 08/06/2008 | CN101234189A Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) |
| 08/06/2008 | CN101234181A Medicament for preventing and treating leukopenia used in tumor radiotherapy and chemotherapy course |
| 08/06/2008 | CN101234128A Paederus extraction liquid and preparation and application thereof |
| 08/06/2008 | CN101234122A New purpose of polylysine |
| 08/06/2008 | CN101234117A Medical use of a pair of ginseng saponin aglycones and their mixture |
| 08/06/2008 | CN101234113A Anti-tumor small molecular compound targeting to phosphatidylethanolamine conjugated protein 4 of human |
| 08/06/2008 | CN101234112A New purpose of cation carbazoles compounds |
| 08/06/2008 | CN101234100A Application of naphthoquinone compounds |
| 08/06/2008 | CN101234098A Application of erianin in preparing medicaments for treating tumor |
| 08/06/2008 | CN101234089A Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof |
| 08/06/2008 | CN101234087A Poside containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234086A Hydroxycamptothecin containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234085A Docetaxel-containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234084A Fluorouracil containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234083A Sustained-release injection containing angiogenic inhibitor thalidomide |
| 08/06/2008 | CN101234082A Sustained-release injection containing angiogenic inhibitor votaranib |
| 08/06/2008 | CN101234081A Sustained-release injection containing angiogenic inhibitor |
| 08/06/2008 | CN101234080A Sustained-release injection containing angiogenic inhibitor and synergistic agent thereof |
| 08/06/2008 | CN101233911A Health seasoning for post-cancer-chemotherapy |
| 08/06/2008 | CN101233883A Method for preparing bead type gynostemma pentaphylla tea |
| 08/06/2008 | CN101233838A Method for inducing spider to generate antibiotic activity substance |
| 08/06/2008 | CN100408694C Transcription active test |
| 08/06/2008 | CN100408683C HLA-A24-restricted cancer antigen peptide |
| 08/06/2008 | CN100408682C MUC-1 antigen with reduced number of VNTR repeat units |
| 08/06/2008 | CN100408597C Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use |
| 08/06/2008 | CN100408594C Lonicera macranthoides active total saponin extract and its preparing method and use |
| 08/06/2008 | CN100408591C Crystal of pyrimidine nucleoside derivative |
| 08/06/2008 | CN100408583C Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 08/06/2008 | CN100408582C Homocamptoth-ecine compounds, their preparation process and use |
| 08/06/2008 | CN100408581C 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 08/06/2008 | CN100408576C Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408098C Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 08/06/2008 | CN100408081C Anti-tumor cancer-diminishing medicine and preparing method |
| 08/06/2008 | CN100408042C Use of ganoderic acid T and ganoderic and Me in tumour growth or proliferation inhibitor |
| 08/06/2008 | CN100408036C Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 08/06/2008 | CN100408032C Stable injection docetaxel |
| 08/06/2008 | CN100408030C Method and pharmaceutical preparations for reducing the activity of cells |
| 08/05/2008 | US7408079 Imaging agents and methods of imaging NAALADase or PSMA |
| 08/05/2008 | US7408063 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/05/2008 | US7408050 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7408039 Induction of chimera mixture; anticancer agents, leukemia |
| 08/05/2008 | US7408037 Polypeptide that, when mixed with a peripheral blood-mononuclear cell culture and incubated, induces cytotoxic T lymphocytes that contain HLA-A2-restricted cytotoxic T lymphocytes; anti-cancer vaccine |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | US7407985 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407971 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407962 Heteroaryl compounds useful as inhibitors or protein kinases |
| 08/05/2008 | US7407952 substance P, integrin receptor antagonist; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; antiinflammatory agent; cell adhesion-mediated disease and central nervous system disorders |
| 08/05/2008 | US7407951 Pyrrolobenzodiazepines |
| 08/05/2008 | US7407946 Quinazoline compounds |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407745 Method for screening anticancer agent |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | US7407649 Silicon compounds and their use |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2331593C Metabolites of ecteinascidin 743 |
| 08/05/2008 | CA2293549C Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2290617C Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
| 08/05/2008 | CA2286796C Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008092103A2 Combination cancer treatments comprising elsamitrucin and other agents |
| 07/31/2008 | WO2008092049A1 Anthranilamide inhibitors of aurora kinase |